A method for preparing lactoferrin with strong iron-absorbing ability

By methacrylation and gradient dialysis technology on lactoferrin, its iron absorption capacity has been significantly improved, the existing iron absorption capacity of lactoferrin is solved, and more efficient iron saturation content and binding location are achieved. Point, suitable for iron overload diseases and antibacterial applications.

CN118271428BActive Publication Date: 2024-12-03MAIRUN MEDICAL TECHNOLOGY (SHAOXING) CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410362552.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-28
Publication Date
2024-12-03
Estimated Expiration
2044-03-28

AI Technical Summary

Technical Problem

The existing lactoferrin has insufficient iron absorption capacity and cannot effectively reduce the iron content in the microenvironment, and its iron saturation content is low, which limits its application in iron reduction therapy and antibacterial.

Method used

By methacrylation treatment of lactoferrin with low iron content, the concentration of PBS solution in the dialysis step is adjusted in combination with a gradient to increase the iron removal efficiency, and the protein is modified by methacrylic anhydride to increase the iron binding site. This improves its iron absorption capacity.

Benefits of technology

It significantly increased the iron saturation content of lactoferrin to 14.43 mg/g, and increased the binding sites to 20, enhancing its iron absorption capacity, and more effectively reducing the iron content in the microenvironment. It is suitable for the treatment of iron overload diseases and Antibacterial.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118271428B_ABST
    Figure CN118271428B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for preparing lactoferrin with strong iron absorption ability, wherein lactoferrin with low iron content is subjected to methacrylation treatment to obtain lactoferrin with strong iron absorption ability; the lactoferrin with low iron content refers to lactoferrin with an iron content lower than 0.15 mg / g; the iron saturation content of the lactoferrin with strong iron absorption ability is greater than 10 mg / g. The method for preparing lactoferrin with strong iron absorption ability of the present invention can enhance the iron absorption ability of lactoferrin by subjecting lactoferrin with low iron content to methacrylation treatment, and the iron saturation content is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of functional proteins and relates to a method for preparing lactoferrin with strong iron-absorbing ability. Background Art

[0002] Lactoferrin is a small molecular weight natural milk-derived glycoprotein with a relative molecular mass of about 80KDa. It is widely present in milk, tears and saliva. Lactoferrin has an iron-absorbing capacity 300 times higher than transferrin and can be used as a natural iron chelator. The sequence of lactoferrin has more than 700 amino acids. Structurally, lactoferrin consists of two globular lobes and the structure is stabilized by disulfide bonds. Past theories believed that the center of each of the two globular lobes of lactoferrin can chelate one iron, and the chelation site is assisted by carbonate provided by the outside world (for example, a certain concentration of carbonate ions in body fluids) to stabilize the chelation site, making it difficult for the iron to dissociate. Lactoferrin will open the iron chelation site and release iron ions in an environment with a pH lower than 4.0; in a neutral environment, apo-lactoferrin can spontaneously re-chelate free iron ions.

[0003] Document 1 (Doi: 10.1016 / j.seppur.2020.117522) records that 0.5800 g EDTA and 0.0300 g lactoferrin were dissolved in 45.0 mL Britton-Robinson buffer (pH = 2.8), stirred at 4 ° C for 30 min, adjusted to pH 7.0, and dialyzed with water in a dialysis bag with a molecular weight cutoff of 3500 Da. Finally, the dialysate was freeze-dried to obtain apolactoferrin powder, and the iron content of apolactoferrin powder was 0.0742 mg / gprot.

[0004] Reference 2 (Doi: 10.3168 / jds.S0022-0302(95)76862-X.) describes that a trivalent iron chelating resin (which has a trivalent iron chelating capacity of 89 μmol / g at pH 6.8) is prepared by polymerization of AHMP and N,N'-bis(acryloyl)-1,2-diaminoethane using N,N'-bis(acryloyl)-1,2-diaminoethane as a crosslinking agent; then 2 ml of an iron-saturated Lf solution (1.4 mg / g), 6 ml of a 0.1 M acetate buffer, and 2 ml of 0.1 M sodium citrate and 50 mg of resin were stirred at room temperature (25°C) for 24 hours, centrifuged at 3000 rpm for 5 minutes to separate the supernatant from the resin, dialyzed in distilled water (3×100 ml) for 3 days, and then freeze-dried to obtain apo-lactoferrin (Apo-Lf). The iron content in Apo-Lf was determined by atomic absorption spectrophotometry to be 0.056 mg / gprot.

[0005] Reference 3 (Doi:10.3168 / jds.S0022-0302(84)81345-4.) states that, first, a 10 mg / ml Lf aqueous solution is prepared, HCl is added to reduce the pH of the Lf aqueous solution to 2.0, and the solution is stirred at room temperature for 3 hours; the Lf solution (50 ml) is added to a 60 ml plastic syringe, and the syringe is mounted on the top of a Dowex-50W ion exchange resin column (1.5×30 cm); the protein solution is eluted through the chromatographic column and collected in an acid-cleaned beaker, and then the chromatographic column is rinsed with 25 ml of deionized distilled water to recover all the protein, thereby obtaining an apolipoprotein solution; 1N NH4OH is carefully added with constant stirring to immediately raise the pH value of the eluted apolipoprotein solution to 7.0, and the pH is adjusted to 4.0. The 7.0 apolipoprotein solution was dialyzed with several volumes of deionized water, then freeze-dried under vacuum and stored at -20°C to obtain apolactoferrin, the iron content of which was 0.21 mg / gprot.

[0006] Patent application CN102459328B provides a method for preparing low-iron lactoferrin, which uses alcohol + acid to obtain low-iron lactoferrin with an iron content of 0.14 mg / g, which has better iron absorption capacity than original lactoferrin and enhances its antimicrobial activity.

[0007] However, the lactoferrin provided in the above prior art has only two iron ion binding sites. As recorded in Document 2, Lf contains 260 μg / g of iron, and the iron content is 18%, so the iron saturation content is about 1.4 mg / gprot.

[0008] The higher the iron saturation content of lactoferrin, the stronger its iron absorption ability. The faster and stronger iron absorption ability enables lactoferrin to quickly reduce the iron content in the microenvironment, better reduce iron to treat iron overload diseases, and has better iron deprivation and antibacterial ability.

[0009] Therefore, it is of great significance to study a method for preparing lactoferrin with strong iron-absorbing ability in order to further improve the iron-absorbing ability. Summary of the invention

[0010] The purpose of the present invention is to solve the problems existing in the prior art and provide a method for preparing lactoferrin with strong iron absorption ability.

[0011] To achieve the above object, the technical solution adopted by the present invention is as follows:

[0012] A method for preparing lactoferrin with strong iron absorption ability, wherein lactoferrin with low iron content is subjected to methacrylic acid acylation to obtain lactoferrin with strong iron absorption ability;

[0013] The low-iron lactoferrin refers to lactoferrin with an iron content lower than 0.15 mg / g;

[0014] The iron saturation content of the lactoferrin with strong iron absorption ability is above 10 mg / g.

[0015] As the preferred technical solution:

[0016] In the method for preparing lactoferrin with strong iron absorption ability as described above, the lactoferrin with low iron content is apo-lactoferrin.

[0017] The method for preparing lactoferrin with strong iron absorption ability as described above comprises the following steps: loading a lactoferrin solution into a dialysis bag, placing the dialysis bag in a PBS solution for dialysis for 48 to 72 hours, and freeze-drying the retentate after dialysis to obtain apolactoferrin; continuously replacing the dialysate PBS solution during the dialysis process, and gradually reducing the concentration of the PBS solution, wherein the concentration of the PBS solution gradually decreases from 0.1M to 0.05M within 0 to 24 hours (excluding 24 hours), the concentration of the PBS solution gradually decreases from 0.05M to 0.01M within 24 to 48 hours (excluding 48 hours), and the concentration of the PBS solution gradually decreases from 0.01M to 0M within 48 to 72 hours.

[0018] The efficiency of iron removal can be increased by gradually reducing the phosphate concentration in the dialysis environment, that is, by continuously bringing out the iron ions released by lactoferrin in an acidic environment through osmotic pressure.

[0019] In the method for preparing lactoferrin with strong iron absorption ability as described above, the lactoferrin solution is prepared by dissolving lactoferrin powder in a mixed solution at room temperature;

[0020] Lactoferrin is lactoferrin from colostrum, milk and whey of cows, humans, camels and other mammals, as well as recombinant lactoferrin obtained by plant fermentation of genetically engineered bacteria;

[0021] The mixed solution is prepared by adding acetic acid, sodium acetate (the molar ratio of acetic acid to sodium acetate is 1:1) and EDTA (sodium ethylenediaminetetraacetate) to a PBS solution with a pH of 2.0 to 4.0; the concentration of PBS in the mixed solution is 0.01M, the total concentration of acetic acid and sodium acetate is 0.1M, and the concentration of EDTA is 40 to 500mM;

[0022] The concentration of lactoferrin solution is 0.5-10g / 100ml.

[0023] The method for preparing lactoferrin with strong iron absorption ability as described above, wherein the process of methacrylating the lactoferrin with low iron content is as follows:

[0024] (1) dissolving low-iron-content lactoferrin in a PBS solution at room temperature to prepare a lactoferrin stock solution with a concentration of 1 to 10 g / 100 ml;

[0025] (2) Add methacrylic anhydride to the lactoferrin stock solution, then adjust the pH value to 6.5-7.5, continue stirring and react at 10-25° C. for 0.5-24 h, dialyze for 24-72 h after the reaction, filter twice with a filter membrane after ultrafiltration concentration, and freeze-dry the filtrate to obtain lactoferrin with strong iron absorption ability.

[0026] In the method for preparing lactoferrin with strong iron absorption ability as described above, the pH value of the PBS solution in step (1) is 2.0-4.0 (adjusted to 2.0-4.0 by acid, the acid is selected from any one of the following: acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, citric acid).

[0027] In the method for preparing lactoferrin with strong iron absorption ability as described above, the usage ratio (v / w) of methacrylic anhydride to lactoferrin in step (2) is 1 mL / 100 g to 2 mL / 1 g.

[0028] In the method for preparing lactoferrin with strong iron absorption ability as described above, the step (2) is completed by adding methacrylic anhydride to the lactoferrin stock solution under high-speed stirring at 400 to 1000 rpm.

[0029] In the method for preparing lactoferrin with strong iron absorption ability as described above, the filtration membrane used for filtration in step (2) has a pore size of 0.1 μm or 0.22 μm.

[0030] Principle of the invention:

[0031] Lactoferrin with low iron content exposes the structure with the strongest iron binding ability in the lactoferrin structure, thus obtaining a strong iron absorption ability. After methacrylation treatment, the surface positive charge density of lactoferrin with low iron content decreases, which is conducive to the entry of iron ions into the protein; and Figure 4 and Figure 6 As shown in the figure, after methacrylation, the 3D conformation of low-iron lactoferrin changes (after the chemical structure changes, the protein automatically adjusts its 3D conformation based on the principle of minimum energy), generating more binding sites for iron. As the number of binding sites for protein-bound iron increases, the protein's ability to absorb iron is greatly improved, and the iron saturation content of lactoferrin increases to more than 10 mg / g.

[0032] Beneficial effects:

[0033] (1) The present invention provides a method for preparing lactoferrin with strong iron absorption ability. The concentration of PBS solution in the dialysis step of the iron removal process is adjusted by gradient, so that the iron removal efficiency can be increased. In addition, the iron absorption ability of lactoferrin can be enhanced by methacrylation of lactoferrin with low iron content. The iron saturation content is increased to 14.43 mg / g at most, and the maximum number of binding sites is increased to 20, that is, the iron ions that can be bound by a unit of lactoferrin are increased by 10 times.

[0034] (2) The present invention provides a method for preparing lactoferrin with strong iron absorption ability. The prepared lactoferrin with strong iron absorption ability can quickly reduce the iron content in the microenvironment, and can better reduce iron to treat iron overload diseases, including but not limited to myocardial ischemia reperfusion, renal ischemia reperfusion, cerebral infarction and other diseases; at the same time, it has better iron deprivation and antibacterial ability. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 The ICP test graphs of the lactoferrin raw material, apo-lactoferrin (Apo-Lf) and lactoferrin with strong iron absorption ability (Apo-LfMA) of Example 1;

[0036] Figure 2 The nuclear magnetic resonance spectra of apo-lactoferrin (Apo-Lf) and lactoferrin with strong iron absorption ability (Apo-LfMA) of Example 1 are shown;

[0037] Figure 3 The MALDI-TOF images of apo-lactoferrin (Apo-Lf) and lactoferrin with strong iron absorption ability (Apo-LfMA) of Example 1 are shown;

[0038] Figure 4 The 3D structural change diagram of Example 1 before and after the lactoferrin (Apo-Lf) with strong iron absorption ability (Apo-LfMA) was obtained by modifying apo-lactoferrin (Apo-Lf) with methacrylic anhydride;

[0039] Figure 5 Schematic diagram of the specific amino acid sites modified by methacrylic anhydride on Apo-Lf;

[0040] Figure 6 This is a molecular docking diagram of lactoferrin (Apo-LfMA) with strong iron absorption ability binding to iron ions, where the sphere represents the iron ions, indicating that the protein chelates 20 iron ions;

[0041] Figures 7 to 16 The detailed 20-site analysis of Apo-LfMA chelating iron after methacrylic anhydride grafting, i.e., the amino acid composition and the chelating force analysis with iron;

[0042] Fig.17The figure is a comparison chart of the iron saturation content of apo-lactoferrin (Apo-Lf) of Example 1 and lactoferrin with strong iron absorption ability (Apo-LfMA);

[0043] Fig.18 The ICP test graph of apo-lactoferrin (Apo-Lf) at pH = 4.0 of Example 2 and pH = 2.0 of Example 1;

[0044] Fig.19 MALDI-TOF of Example 3 with a methacrylic anhydride grafting degree of 10% (10% Apo-LfMA) and Example 4 with a methacrylic anhydride grafting degree of 100% (100% Apo-LfMA);

[0045] Fig. 20 The iron saturation content of the methacrylic anhydride grafting degree of 10% (10% Apo-LfMA) of Example 3 and the methacrylic anhydride grafting degree of 100% (100% Apo-LfMA) of Example 4; DETAILED DESCRIPTION

[0046] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0047] The test method involved in the present invention is as follows:

[0048] Iron content: Add 1 ml of concentrated nitric acid to 5 mg of protein powder, digest at 70°C for 1 hour, cool to room temperature and dilute with deionized water to 5 ml. The diluted solution is sent for inductively coupled plasma (ICP) testing of iron ion concentration. The obtained concentration value a ug / mL is equal to the iron content a mg / g in the protein.

[0049] Iron saturation content: Dissolve 100 mg of protein in 50 mL of FeCl3 / NaHCO3 (molar ratio 1:1) solution with a concentration of 50 μg / mL and a pH value of 7.2-7.4, and stir for 30 minutes. Centrifuge the mixture in a 50 kDa ultrafiltration tube to remove excess unbound iron ions, and wash the protein with deionized water 3 times until all unbound iron ions are removed, and then freeze-dry the protein into powder. Add 1 ml of concentrated nitric acid to 5 mg of freeze-dried protein powder, digest at 70°C for 1 hour, cool to room temperature, and dilute to 5 ml with deionized water. The diluted solution is sent for inductively coupled plasma (ICP) testing of iron ion concentration. The obtained concentration value a μg / mL is equal to the iron saturation content a mg / g in the protein.

[0050] Example 1

[0051] A method for preparing lactoferrin with strong iron absorption ability, the specific steps are as follows:

[0052] (1) adding acetic acid, sodium acetate (molar ratio of 1:1) and EDTA to a PBS solution with a pH of 2.0 to obtain a mixed solution, and then dissolving lactoferrin powder (Bega, Australia) in the mixed solution at room temperature to obtain a lactoferrin solution with a concentration of 0.5 g / 100 ml;

[0053] The concentration of PBS in the mixed solution was 0.01 M, the total concentration of acetic acid and sodium acetate was 0.1 M, and the concentration of EDTA was 500 mM;

[0054] (2) the lactoferrin solution obtained in step (1) is placed in a dialysis bag, the dialysis bag is placed in a PBS solution for dialysis for 72 hours, the retentate after dialysis is pre-frozen at a temperature of -50°C, and then lyophilized under a vacuum condition of 1 Pa to obtain apolactoferrin with an iron content of 0.0139 mg / g; the PBS solution is continuously replaced during the dialysis process, and the concentration of the PBS solution is gradually reduced, and the concentration of the PBS solution is gradually reduced from 0.1M to 0.05M within 0-24 hours, the concentration of the PBS solution is gradually reduced from 0.05M to 0.01M within 24-48 hours, and the concentration of the PBS solution is gradually reduced from 0.01M to 0M within 48-72 hours;

[0055] Among them, the molecular weight cut-off of the dialysis bag is 3500Da;

[0056] (3) performing methacrylation on the apolactoferrin obtained in step (2) to obtain lactoferrin having a strong iron absorption capacity;

[0057] (3.1) dissolving apolactoferrin in a PBS solution with a pH value of 2 at room temperature to prepare an apolactoferrin stock solution with a concentration of 10 g / 100 ml;

[0058] (3.2) under high-speed stirring at 600 rpm, methacrylic anhydride was added to the apolactoferrin stock solution, and then the pH value was adjusted to 7, and the reaction was continued with stirring at 25° C. for 2 h, and the reaction was dialyzed for 48 h. After ultrafiltration and concentration, the solution was filtered twice with a filter membrane with a pore size of 0.22 μm, and the filtrate was pre-frozen at a temperature of -50° C. and then freeze-dried under a vacuum condition of 1 Pa to obtain lactoferrin with a saturated content of trivalent iron of 14.43 mg / g and strong iron absorption capacity;

[0059] The dosage ratio of methacrylic anhydride to lactoferrin is 0.03 mL / 1 g, and the grafting degree of methacrylic anhydride on lactoferrin with strong iron absorption ability is 30%.

[0060] like Figure 1 As shown, by de-ironification, Apo-Lf and Apo-LfMA were obtained, with iron contents of 0.98% and 0.85% of Lf, respectively;

[0061] like Figures 2-3 As shown, methacrylic anhydride successfully grafted reactive double bonds onto Apo-Lf, and thus the molecular weight of Apo-LfMA increased after methacrylation.

[0062] like Figure 4 The 3D structural changes of Apo-Lf and Apo-LfMA before and after methacrylic anhydride grafting (protein morphology constructed by AlphaFold) are shown. Figure 5 The figure shows the specific amino acid (lysine) sites modified by methacrylic anhydride on Apo-Lf. The specific 14 sites are shown in Table 1 below; wherein the lowercase k is the modification position of the specific lysine, and the new Apo-LfMA protein structure is obtained for subsequent molecular docking analysis of iron ions;

[0063] Through molecular docking of Apo-LfMA and iron ions, it was found that there are 20 iron chelating sites of Apo-LfMA after methacrylic anhydride grafting. The specific analysis of the 20 sites is shown in the figure below. Figures 7 to 16 shown.

[0064] Table 1

[0065] K46 FKCRRWQWRMkKLGAPSITCV K47 KCRRWQWRMKkLGAPSITCVR K71 ALECIRAIAEkKADAVTLDGG K288 SVDGKEDLIWkLLSKAQEKFG K296 IWKLLSKAQEkFGKNKSRSFQ K301 SKAQEKFGKNkSRSFQLFGSP K320 SPPGQRDLLFkDSALGFLRIP K332 SALGFLRIPSkVDSALYLGSR K348 YLGSRYLTTLkNLRETAEEVK K358 KNLRETAEEVkARYTRVVWCA K460 EGYLAVAVVKkANEGLTWNSL K539 QGLDKCVPNSkEKYYGYTGAF K627 VSRSDRAAHVkQVLLHQQALF K652 KNCPDKFCLFkSETKNLLFND

[0066] like Fig.17 As shown, the saturated content of lactoferrin bound to trivalent iron increased significantly after methacryloylation.

[0067] Example 2

[0068] A method for preparing lactoferrin with strong iron absorption ability, the specific steps are as follows:

[0069] (1) adding acetic acid, sodium acetate (molar ratio of 1:1) and EDTA to a PBS solution with a pH of 4.0 to obtain a mixed solution, and then dissolving lactoferrin powder (Bega, Australia) in the mixed solution at room temperature to obtain a lactoferrin solution with a concentration of 10 g / 100 ml;

[0070] The concentration of PBS in the mixed solution was 0.01 M, the total concentration of acetic acid and sodium acetate was 0.1 M, and the concentration of EDTA was 40 mM;

[0071] (2) the lactoferrin solution obtained in step (1) is placed in a dialysis bag, the dialysis bag is placed in a PBS solution for dialysis for 72 hours, the retentate after dialysis is pre-frozen at a temperature of -50°C, and then lyophilized under a vacuum condition of 1 Pa to obtain apolactoferrin with an iron content of 0.149 mg / g; the PBS solution is continuously replaced during the dialysis process, and the concentration of the PBS solution is gradually reduced, and the concentration of the PBS solution is gradually reduced from 0.1M to 0.05M within 0-24 hours, the concentration of the PBS solution is gradually reduced from 0.05M to 0.01M within 24-48 hours, and the concentration of the PBS solution is gradually reduced from 0.01M to 0M within 48-72 hours;

[0072] Among them, the molecular weight cut-off of the dialysis bag is 7000Da;

[0073] like Fig.18 As shown, increasing the deferrification pH to 4.0 in Example 2 will reduce the deferrification efficiency. The iron content of Apo-lf obtained by deferrification at pH = 4.0 is 0.149 mg / g, which is 10 times higher than that in Example 1 at pH = 2.0;

[0074] (3) performing methacrylation on the apolactoferrin obtained in step (2) to obtain lactoferrin having a strong iron absorption capacity;

[0075] (3.1) dissolving apolactoferrin in a PBS solution with a pH value of 4 at room temperature to prepare an apolactoferrin stock solution with a concentration of 10 g / 100 ml;

[0076] (3.2) under high-speed stirring at 600 rpm, methacrylic anhydride was added to the apoptotic lactoferrin stock solution, and then the pH value was adjusted to 7.2, and the reaction was continued with stirring at 25° C. for 2 h, and the reaction was dialyzed for 48 h. After ultrafiltration and concentration, the solution was filtered twice with a filter membrane with a pore size of 0.22 μm, and the filtrate was pre-frozen at a temperature of -50° C. and then freeze-dried under a vacuum condition of 1 Pa to obtain lactoferrin with a saturated content of trivalent iron of 14.43 mg / g and strong iron absorption capacity;

[0077] The dosage ratio of methacrylic anhydride to lactoferrin is 0.03 mL / 1 g, and the grafting degree of methacrylic anhydride on lactoferrin with strong iron absorption ability is 30%.

[0078] Example 3

[0079] A method for preparing lactoferrin with strong iron absorption ability, the specific steps are as follows:

[0080] (1) adding acetic acid, sodium acetate (molar ratio of 1:1) and EDTA into a PBS solution to obtain a mixed solution, and then dissolving lactoferrin powder (Bega, Australia) in the mixed solution at room temperature to obtain a lactoferrin solution with a concentration of 0.5 g / 100 ml;

[0081] The concentration of PBS in the mixed solution was 0.01 M, the total concentration of acetic acid and sodium acetate was 0.1 M, and the concentration of EDTA was 500 mM;

[0082] (2) the lactoferrin solution obtained in step (1) is placed in a dialysis bag, the dialysis bag is placed in a PBS solution for dialysis for 72 hours, the retentate after dialysis is pre-frozen at a temperature of -50°C, and then freeze-dried under a vacuum condition of 1 Pa to obtain apolactoferrin with an iron content of 0.0139 mg / g; the PBS solution is continuously replaced during the dialysis process, and the concentration of the PBS solution is gradually reduced. The concentration of the PBS solution is gradually reduced from 0.1M to 0.05M within the 0th to 24th hour, the concentration of the PBS solution is gradually reduced from 0.05M to 0.01M within the 24th to 48th hour, and the concentration of the PBS solution is gradually reduced from 0.01M to 0M within the 48th to 72th hour;

[0083] Among them, the molecular weight cut-off of the dialysis bag is 7000Da;

[0084] (3) performing methacrylation on the apolactoferrin obtained in step (2) to obtain lactoferrin having a strong iron absorption capacity;

[0085] (3.1) dissolving apolactoferrin in a PBS solution with a pH value of 2 at room temperature to prepare an apolactoferrin stock solution with a concentration of 10 g / 100 ml;

[0086] (3.2) Under high-speed stirring at 400 rpm, methacrylic anhydride was added to the apoptotic lactoferrin stock solution, and then the pH value was adjusted to 7.5, and the reaction was continued with stirring at 20°C for 5 hours. After the reaction, it was dialyzed for 48 hours, and then ultrafiltration and concentration were performed. The filter was filtered twice with a filter membrane with a pore size of 0.22 μm. The filtrate was pre-frozen at a temperature of -50°C, and then freeze-dried under a vacuum condition of 1 Pa to obtain Figures 19-20 The lactoferrin shown has a saturated content of 10.95 mg / g of ferric iron and has a strong iron-absorbing ability;

[0087] The dosage ratio of methacrylic anhydride to lactoferrin is 0.01 mL / 1 g, and the grafting degree of methacrylic anhydride on lactoferrin with strong iron absorption ability is 10%.

[0088] Example 4

[0089] A method for preparing lactoferrin with strong iron absorption ability, the specific steps are as follows:

[0090] (1) adding acetic acid, sodium acetate (molar ratio of 1:1) and EDTA into a PBS solution to obtain a mixed solution, and then dissolving lactoferrin powder (Bega, Australia) in the mixed solution at room temperature to obtain a lactoferrin solution with a concentration of 10 g / 100 ml;

[0091] The concentration of PBS in the mixed solution was 0.01 M, the total concentration of acetic acid and sodium acetate was 0.1 M, and the concentration of EDTA was 500 mM;

[0092] (2) the lactoferrin solution obtained in step (1) is placed in a dialysis bag, the dialysis bag is placed in a PBS solution for dialysis for 72 hours, the retentate after dialysis is pre-frozen at a temperature of -50°C, and then lyophilized under a vacuum condition of 1 Pa to obtain apolactoferrin with an iron content of 0.0139 mg / g; the PBS solution is continuously replaced during the dialysis process, and the concentration of the PBS solution is gradually reduced, the concentration of the PBS solution is 0.1 M within 0 to 24 hours, the concentration of the PBS solution is 0.05 M within 24 to 48 hours, and the concentration of the PBS solution is 0 M within 48 to 72 hours;

[0093] Among them, the molecular weight cut-off of the dialysis bag is 7000Da;

[0094] (3) performing methacrylation on the apolactoferrin obtained in step (2) to obtain lactoferrin having a strong iron absorption capacity;

[0095] (3.1) dissolving apolactoferrin in a PBS solution with a pH value of 2 at room temperature to prepare an apolactoferrin stock solution with a concentration of 1 g / 100 ml;

[0096] (3.2) Under high-speed stirring at 1000 rpm, methacrylic anhydride was added to the apoptotic lactoferrin stock solution, and then the pH value was adjusted to 6.5, and the reaction was continued at 10°C with stirring for 24 hours. After the reaction, the solution was dialyzed for 72 hours, and then ultrafiltration and concentration were performed, and the solution was filtered twice with a filter membrane with a pore size of 0.22 μm. The filtrate was pre-frozen at a temperature of -50°C, and then freeze-dried under a vacuum condition of 1 Pa to obtain Figures 19-20 The lactoferrin with strong iron absorption capacity has a saturated content of 12.46 mg / g of trivalent iron;

[0097] The dosage ratio of methacrylic anhydride to lactoferrin is 2 mL / 1 g, and the grafting degree of methacrylic anhydride on lactoferrin with strong iron absorption ability is 100%.

Claims

1. A method for preparing lactoferrin with strong iron absorption ability, characterized in that: Lactoferrin with low iron content was treated with methacryloylation to obtain lactoferrin with strong iron absorption ability. The low-iron lactoferrin refers to lactoferrin with an iron content lower than 0.15 mg / g; The iron saturation content of the lactoferrin with strong iron absorption ability is above 10 mg / g.

2. The method for preparing lactoferrin with strong iron absorption ability according to claim 1, characterized in that: The lactoferrin with low iron content is apolactoferrin.

3. The method for preparing lactoferrin with strong iron absorption ability according to claim 2, characterized in that: The preparation method of apolactoferrin comprises the following steps: loading a lactoferrin solution into a dialysis bag, placing the dialysis bag in a PBS solution for dialysis for 48 to 72 hours, and freeze-drying the retentate after dialysis to obtain apolactoferrin; during the dialysis process, the concentration of the PBS solution gradually decreases, the concentration of the PBS solution gradually decreases from 0.1M to 0.05M within 0 to 24 hours, the concentration of the PBS solution gradually decreases from 0.05M to 0.01M within 24 to 48 hours, and the concentration of the PBS solution gradually decreases from 0.01M to 0M within 48 to 72 hours.

4. The method for preparing lactoferrin with strong iron absorption ability according to claim 3, characterized in that: The lactoferrin solution is prepared by dissolving lactoferrin powder in a mixed solution at room temperature; The mixed solution is prepared by adding acetic acid, sodium acetate and EDTA to a PBS solution with a pH of 2.0 to 4.0; the concentration of PBS in the mixed solution is 0.01M, the total concentration of acetic acid and sodium acetate is 0.1M, and the concentration of EDTA is 40 to 500mM; The concentration of lactoferrin solution is 0.5-10g / 100ml.

5. The method for preparing lactoferrin with strong iron absorption ability according to claim 1, characterized in that: The process of methacrylation of low iron lactoferrin is as follows: (1) dissolving low-iron-content lactoferrin in a PBS solution at room temperature to prepare a lactoferrin stock solution with a concentration of 1 to 10 g / 100 ml; (2) Add methacrylic anhydride to the lactoferrin stock solution, then adjust the pH value to 6.5-7.5, continue stirring and react at 10-25° C. for 0.5-24 h, dialyze for 24-72 h after the reaction, filter twice with a filter membrane after ultrafiltration concentration, and freeze-dry the filtrate to obtain lactoferrin with strong iron absorption ability.

6. The method for preparing lactoferrin with strong iron absorption ability according to claim 5, characterized in that: The pH value of the PBS solution in step (1) is 2.0 to 4.

0.

7. The method for preparing lactoferrin with strong iron absorption ability according to claim 5, characterized in that: In step (2), the usage ratio of methacrylic anhydride to lactoferrin is 1 mL / 100 g to 2 mL / 1 g.

8. The method for preparing lactoferrin with strong iron absorption ability according to claim 5, characterized in that: In step (2), methacrylic anhydride is added to the lactoferrin stock solution under high-speed stirring at 400 to 1000 rpm.

9. The method for preparing lactoferrin with strong iron absorption ability according to claim 5, characterized in that: The pore size of the filter membrane used for filtration in step (2) is 0.1 μm or 0.22 μm.

Citation Information

Patent Citations

  • Method of preparing low-iron lactoferrin

    CN102459328B

  • Lactoferrin for the treatment of IBD associated with bacterial invasion

    CN105744947A

  • Method for extracting and preparing high-purity low-iron-saturation lactoferrin from cow milk

    CN106008703A

  • Preparation method and application of methacrylated whey protein hydrogel

    CN113388133A

  • Method for isolating lactoferrin isophome from whey

    JP2001170501A